Abstract:Background—In patients with severe heart failure and dilated cardiomyopathy, cardiac resynchronization therapy (CRT) improves left ventricular (LV) systolic function associated with LV reverse remodeling and favorable 1-year survival. However, it is unknown whether LV reverse remodeling translates into a better long-term prognosis and what extent of reverse remodeling is clinically relevant, which were investigated in this study. Methods and Results—Patients (n=141) with advanced heart failure (mean±SD age, 64±11 years; 73% men) who received CRT were followed up for a mean (±SD) of 695±491 days. The extent of reduction in LV end-systolic volume (LVESV) at 3 to 6 months relative to baseline was examined for its predictive value on long-term clinical outcome. The cutoff value for LV reverse remodeling in predicting mortality was derived from the receiver operating characteristic curve. Then the relation between potential predictors of mortality and heart failure hospitalizations were compared by Kaplan-Meier survival analysis, followed by Cox regression analysis. There were 22 (15.6%) deaths, mostly due to heart failure or sudden cardiac death. The receiver operating characteristic curve found that a reduction in LVESV of ≥9.5% had a sensitivity of 70% and specificity of 70% in predicting all-cause mortality and of 87% and 69%, respectively, for cardiovascular mortality. With this cutoff value, there were 87 (61.7%) responders to reverse remodeling. In Kaplan-Meier survival analysis, responders had significantly lower all-cause morality (6.9% versus 30.6%, log-rank &khgr;2=13.26, P=0.0003), cardiovascular mortality (2.3% versus 24.1%, log-rank &khgr;2=17.1, P<0.0001), and heart failure events (11.5% versus 33.3%, log-rank &khgr;2=8.71, P=0.0032) than nonresponders. In the Cox regression analysis model, the change in LVESV was the single most important predictor of all-cause (&bgr;=1.048, 95% confidence interval=1.019 to 1.078, P=0.001) and cardiovascular (&bgr;=1.072, 95% confidence interval=1.033 to 1.112, P<0.001) mortality. Clinical parameters were unable to predict any outcome event. Conclusions—A reduction in LVESV of 10% signifies clinically relevant reverse remodeling, which is a strong predictor of lower long-term mortality and heart failure events. This study suggests that assessing volumetric changes after an intervention in patients with heart failure provides information predictive of natural history outcomes.

Analysis on Improvement of Left Ventricular End Diastolic Diameter after Cardiac Resynchronization Therapy

Clinical Effect of Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure

[Factors Associated with the Efficacy of Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure].

The clinical effect of quadripolar left ventricular lead in CRT therapy

Relation of Late Gadolinium Enhancement in Cardiac Magnetic Resonance on the Diastolic Volume Recovery of Left Ventricle with Hypertrophic Cardiomyopathy.

Predictors for Cardiac Resynchronization Therapy Response

Long-term effects of cardiac resynchronization therapy in patients with congestive heart failure

Differential Change in Left Ventricular Mass and Regional Wall Thickness after Cardiac Resynchronization Therapy for Heart Failure

Impact of left ventricular lead position on clinical outcome of cardiac resynchronization therapy.

Relationship between ventricular electrical remodeling and ventricular arrhythmias and left ventricular remodeling reverse after cardiac resynchronization therapy

Determination of Optimal Left Ventricular Pacing Site for Cardiac Resynchronization Therapy by Tissue Doppler Imaging

Impact of postoperative QRS duration change on cardiac resynchronization therapy

Analysis of related factors of poor recovery of left ventricular ejection function after ischemic cardiomyopathy CABG

Relationship of Mechanical Dyssynchrony and LV Remodeling With Improvement of Mitral Regurgitation After CRT

Electro-echocardiographic Indices to Predict Cardiac Resynchronization Therapy Non-response on Non-ischemic Cardiomyopathy

Improvement of Atrial Function and Atrial Reverse Remodeling after Cardiac Resynchronization Therapy for Heart Failure

Are left ventricular diastolic function and diastolic asynchrony important determinants of response to cardiac resynchronization therapy?

Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy

Efficacy research of cardiac resynchronization therapy in heart failure with narrow QRS complexes

CMR Feature Tracking-Based Left Atrial Mechanics Predicts Response to Cardiac Resynchronization Therapy and Adverse Outcomes.

Left Ventricular Reverse Remodeling but Not Clinical Improvement Predicts Long-Term Survival after Cardiac Resynchronization Therapy